Haemonetics | HAE - Operating Profit


Haemonetics reported $75.12M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Boston Scientific USD 1.01B 232M Sep/2026
Cerus USD -1.45M 488K Dec/2024
Cooper Companies USD 222M 253M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 153.27M Sep/2026
Globus Medical USD 178.23M 224.2M Sep/2026
Haemonetics USD 75.12M 17.66M Sep/2026
ICU Medical USD 58.59M 1.84M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Neogen USD -1.8M 4.9M Jun/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Quidel USD 12.1M 27.4M Sep/2026
ResMed USD 454.34M 51.33M Jun/2026
STAAR Surgical USD 5.46M 4.64M Sep/2026
Steris USD 319.2M 33.4M Sep/2026
Stryker USD 1.79B 687M Jun/2026
Teleflex USD -105.77M 178.84M Sep/2026
Terumo JPY -18.68B 108.16B Sep/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
US Physical Therapy USD -78K 16.47M Sep/2026
Zimmer Biomet Holdings USD 341.5M 3.2M Sep/2026